Mystic Asset Management, Inc.
Source: SEC Form 13F · as of Mar 2026Mystic Asset Management, Inc. holds 17 biotech & pharma companies tracked by BioSniper, totaling $39.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$39.3M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 28,927 | $7.1M |
| PFEPFIZER INC | 179,704 | $5.0M |
| ABBVAbbVie Inc. | 20,315 | $4.4M |
| ZVRAZEVRA THERAPEUTICS, INC. | 361,283 | $3.4M |
| MRKMerck & Co., Inc. | 24,445 | $2.9M |
| ABTABBOTT LABORATORIES | 25,358 | $2.6M |
| LLYELI LILLY & Co | 2,606 | $2.4M |
| PMPhilip Morris International Inc | 13,719 | $2.3M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 7,390 | $2.0M |
| NVSNovartis AG | 9,169 | $1.4M |
| SUPNSUPERNUS PHARMACEUTICALS, INC. | 25,700 | $1.3M |
| BMYBRISTOL MYERS SQUIBB CO | 21,275 | $1.3M |
| ZTSZoetis Inc. | 9,623 | $1.1M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 2,000 | $893K |
| NVONovo Nordisk A/S | 12,425 | $457K |
| AMGNAMGEN INC | 1,280 | $450K |
| GILDGILEAD SCIENCES, INC. | 1,769 | $247K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.